Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000672107 | SCV000797172 | uncertain significance | Retinitis pigmentosa 26 | 2018-01-19 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001857209 | SCV002259489 | uncertain significance | not provided | 2024-02-17 | criteria provided, single submitter | clinical testing | This sequence change falls in intron 3 of the CERKL gene. It does not directly change the encoded amino acid sequence of the CERKL protein. It affects a nucleotide within the consensus splice site. This variant is present in population databases (rs766131721, gnomAD 0.002%). This variant has been observed in individual(s) with retinitis pigmentosa (PMID: 28041643). ClinVar contains an entry for this variant (Variation ID: 438055). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Baylor Genetics | RCV000672107 | SCV004216798 | likely pathogenic | Retinitis pigmentosa 26 | 2023-08-31 | criteria provided, single submitter | clinical testing | |
NIHR Bioresource Rare Diseases, |
RCV000504980 | SCV000598882 | likely pathogenic | Retinitis pigmentosa | 2015-01-01 | no assertion criteria provided | research |